PATENT CLAIM ANALYSIS

Application Number: 15978692
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).

Claim (Index 14):
The immunotherapeutic composition of  claim 13 , wherein the anti-toxin agent is a mono-specific, bi-specific or multi-specific antibody with specificity toward a bacterial or fungal toxin.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 93.0
- Lexical Diversity: 1.82
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14592727', '14790872', '15811486', '14592721', '15460147']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8734343041103445
- 35 USC 102 Novelty (BERT): 0.7346342803652065
- Combined Prediction Score: 0.8595543017358307
- Mean Citation Score: 677.0751379999998
- Max Citation Score: 774.59973
- Similarity Product: 670.1028301029253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test